These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
351 related articles for article (PubMed ID: 29663362)
1. CD69 partially inhibits apoptosis and erythroid differentiation via CD24, and their knockdown increase imatinib sensitivity in BCR-ABL-positive cells. Huang SY; Liu YH; Chen YJ; Yeh YY; Huang HM J Cell Physiol; 2018 Sep; 233(9):7467-7479. PubMed ID: 29663362 [TBL] [Abstract][Full Text] [Related]
2. Activin A downregulates the CD69-MT2A axis via p38MAPK to induce erythroid differentiation that sensitizes BCR-ABL-positive cells to imatinib. Chen CW; Huang NK; Lee YL; Fan CK; Chen YC; Liu CW; Huang HM Exp Cell Res; 2022 Aug; 417(2):113219. PubMed ID: 35643179 [TBL] [Abstract][Full Text] [Related]
3. Aclacinomycin A sensitizes K562 chronic myeloid leukemia cells to imatinib through p38MAPK-mediated erythroid differentiation. Lee YL; Chen CW; Liu FH; Huang YW; Huang HM PLoS One; 2013; 8(4):e61939. PubMed ID: 23613979 [TBL] [Abstract][Full Text] [Related]
4. Apoptosis and erythroid differentiation triggered by Bcr-Abl inhibitors in CML cell lines are fully distinguishable processes that exhibit different sensitivity to caspase inhibition. Jacquel A; Colosetti P; Grosso S; Belhacene N; Puissant A; Marchetti S; Breittmayer JP; Auberger P Oncogene; 2007 Apr; 26(17):2445-58. PubMed ID: 17043649 [TBL] [Abstract][Full Text] [Related]
5. Novel agent nitidine chloride induces erythroid differentiation and apoptosis in CML cells through c-Myc-miRNAs axis. Liu N; Li P; Zang S; Liu Q; Ma D; Sun X; Ji C PLoS One; 2015; 10(2):e0116880. PubMed ID: 25647305 [TBL] [Abstract][Full Text] [Related]
6. MPT0B169, a New Antitubulin Agent, Inhibits Bcr-Abl Expression and Induces Mitochondrion-Mediated Apoptosis in Nonresistant and Imatinib-Resistant Chronic Myeloid Leukemia Cells. Wong SM; Liu FH; Lee YL; Huang HM PLoS One; 2016; 11(1):e0148093. PubMed ID: 26815740 [TBL] [Abstract][Full Text] [Related]
7. Spred2 modulates the erythroid differentiation induced by imatinib in chronic myeloid leukemia cells. Yang Y; Liu X; Xiao F; Xue S; Xu Q; Yin Y; Sun H; Xu J; Wang H; Zhang Q; Wang H; Wang L PLoS One; 2015; 10(2):e0117573. PubMed ID: 25688862 [TBL] [Abstract][Full Text] [Related]
8. The antiproliferation effect of berbamine on k562 resistant cells by inhibiting NF-kappaB pathway. Wei YL; Liang Y; Xu L; Zhao XY Anat Rec (Hoboken); 2009 Jul; 292(7):945-50. PubMed ID: 19548306 [TBL] [Abstract][Full Text] [Related]
9. p19 Kuang Y; Han X; Cao P; Xiong D; Peng Y; Liu Z; Xu Z; Liang L; Roy M; Liu J; Nie L; Zhang J Blood Cells Mol Dis; 2020 Nov; 85():102477. PubMed ID: 32711219 [TBL] [Abstract][Full Text] [Related]
10. EPS8 regulates proliferation, apoptosis and chemosensitivity in BCR-ABL positive cells via the BCR-ABL/PI3K/AKT/mTOR pathway. Huang R; Liu H; Chen Y; He Y; Kang Q; Tu S; He Y; Zhou X; Wang L; Yang J; Wu A; Li Y Oncol Rep; 2018 Jan; 39(1):119-128. PubMed ID: 29192326 [TBL] [Abstract][Full Text] [Related]
11. Alantolactone induces apoptosis in chronic myelogenous leukemia sensitive or resistant to imatinib through NF-κB inhibition and Bcr/Abl protein deletion. Wei W; Huang H; Zhao S; Liu W; Liu CX; Chen L; Li JM; Wu YL; Yan H Apoptosis; 2013 Sep; 18(9):1060-70. PubMed ID: 23613107 [TBL] [Abstract][Full Text] [Related]
12. Targeting Hedgehog signaling pathway and autophagy overcomes drug resistance of BCR-ABL-positive chronic myeloid leukemia. Zeng X; Zhao H; Li Y; Fan J; Sun Y; Wang S; Wang Z; Song P; Ju D Autophagy; 2015; 11(2):355-72. PubMed ID: 25701353 [TBL] [Abstract][Full Text] [Related]
13. Overexpression of Tpl2 is linked to imatinib resistance and activation of MEK-ERK and NF-κB pathways in a model of chronic myeloid leukemia. Chorzalska A; Ahsan N; Rao RSP; Roder K; Yu X; Morgan J; Tepper A; Hines S; Zhang P; Treaba DO; Zhao TC; Olszewski AJ; Reagan JL; Liang O; Gruppuso PA; Dubielecka PM Mol Oncol; 2018 May; 12(5):630-647. PubMed ID: 29485707 [TBL] [Abstract][Full Text] [Related]
14. A novel tubulin polymerization inhibitor, MPT0B206, downregulates Bcr-Abl expression and induces apoptosis in imatinib-sensitive and imatinib-resistant CML cells. Chen CW; Lee YL; Liou JP; Liu YH; Liu CW; Chen TY; Huang HM Apoptosis; 2016 Sep; 21(9):1008-18. PubMed ID: 27344662 [TBL] [Abstract][Full Text] [Related]
16. Experimental and integrative analyses identify an ETS1 network downstream of BCR-ABL in chronic myeloid leukemia (CML). Desterke C; Voldoire M; Bonnet ML; Sorel N; Pagliaro S; Rahban H; Bennaceur-Griscelli A; Cayssials E; Chomel JC; Turhan AG Exp Hematol; 2018 Aug; 64():71-83.e8. PubMed ID: 29733872 [TBL] [Abstract][Full Text] [Related]
17. Potential role of Notch signalling in CD34+ chronic myeloid leukaemia cells: cross-talk between Notch and BCR-ABL. Aljedai A; Buckle AM; Hiwarkar P; Syed F PLoS One; 2015; 10(4):e0123016. PubMed ID: 25849484 [TBL] [Abstract][Full Text] [Related]
18. Nickel pyrithione induces apoptosis in chronic myeloid leukemia cells resistant to imatinib via both Bcr/Abl-dependent and Bcr/Abl-independent mechanisms. Lan X; Zhao C; Chen X; Zhang P; Zang D; Wu J; Chen J; Long H; Yang L; Huang H; Carter BZ; Wang X; Shi X; Liu J J Hematol Oncol; 2016 Nov; 9(1):129. PubMed ID: 27884201 [TBL] [Abstract][Full Text] [Related]
19. Silencing of suppressor of cytokine signaling-3 due to methylation results in phosphorylation of STAT3 in imatinib resistant BCR-ABL positive chronic myeloid leukemia cells. Al-Jamal HA; Jusoh SA; Yong AC; Asan JM; Hassan R; Johan MF Asian Pac J Cancer Prev; 2014; 15(11):4555-61. PubMed ID: 24969884 [TBL] [Abstract][Full Text] [Related]
20. Arsenic sulfide nanoformulation induces erythroid differentiation in chronic myeloid leukemia cells through degradation of BCR-ABL. Wang T; Wen T; Li H; Han B; Hao S; Wang C; Ma Q; Meng J; Liu J; Xu H Int J Nanomedicine; 2019; 14():5581-5594. PubMed ID: 31413564 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]